Nijmegen Breakage Syndrome
|
1.000 |
Biomarker
|
disease |
CTD_human |
[Increased risk of malignancies in heterozygotes in families of patients with Nijmegen breakage syndrome].
|
16521404 |
2006 |
Multiple Chronic Conditions
|
0.010 |
Biomarker
|
disease |
BEFREE |
Xrs2/Nbs1 is a multi-functional regulatory subunit of the Mre11-Rad50-Xrs2/Nbs1 (MRX/N) complex, and its function is critical for the primary step of DSB repair, whether by homologous recombination (HR) or non-homologous end joining.
|
26990569 |
2016 |
Chronic Kidney Diseases
|
0.020 |
Biomarker
|
group |
BEFREE |
While DRV/r use was not significantly associated with CKD an increasing incidence with longer ATV/r use was confirmed.
|
31504669 |
2019 |
Malignant Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Whereas these outcomes are associated with predisposition to malignancy in humans, similar predisposition was not observed in either Mre11(ATLD1/ATLD1) or Nbs1(DeltaB/DeltaB) mice.
|
15034299 |
2004 |
Primary malignant neoplasm
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Whereas these outcomes are associated with predisposition to malignancy in humans, similar predisposition was not observed in either Mre11(ATLD1/ATLD1) or Nbs1(DeltaB/DeltaB) mice.
|
15034299 |
2004 |
Endometrial Carcinoma
|
0.120 |
AlteredExpression
|
disease |
BEFREE |
When matched to a cohort of 107 breast tumors based on HercepTest HER2 expression, high grade EnCa presented with higher p95 levels (p<0.001).
|
25602714 |
2015 |
Malignant neoplasm of endometrium
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
When matched to a cohort of 107 breast tumors based on HercepTest HER2 expression, high grade EnCa presented with higher p95 levels (p<0.001).
|
25602714 |
2015 |
Cerebellar atrophy
|
0.010 |
Biomarker
|
disease |
BEFREE |
When Nbs1 is conditionally inactivated in the central nervous system of mice (Nbs1-CNS-Δ), they suffer from severe cerebellar atrophy, ataxia, and white matter damage.
|
21279473 |
2011 |
Nijmegen Breakage Syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
We used here antisense oligonucleotides to enforce alternative splicing in NBS patient cells and efficiently generate the same internally deleted p80-nibrin protein.
|
26265251 |
2016 |
Carcinogenesis
|
0.080 |
Biomarker
|
phenotype |
BEFREE |
We thus cannot exclude a possible role of NBN in the tumorigenesis of a certain type of astrocytic tumors.
|
19629396 |
2010 |
Carcinoma breast stage IV
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
We then measured H3T in 89 patients with metastatic breast cancer treated with trastuzumab-based therapy, and correlated the results with progression-free survival and overall survival using Kaplan–Meier and decision tree analyses that also included HER2 total (H2T) and p95 expression levels.
|
23959396 |
2013 |
Microcephaly
|
0.160 |
GeneticVariation
|
disease |
BEFREE |
We tested 67 Czech patients of different ages with simple microcephaly for the presence of the most common mutation in the NBS1 gene.
|
15033202 |
2004 |
Malignant neoplasm of breast
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
We screened 235 non-BRCA1/2 Korean patients with high-risk breast cancer for NBS1 mutations.
|
25712764 |
2015 |
Breast Carcinoma
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
We screened 235 non-BRCA1/2 Korean patients with high-risk breast cancer for NBS1 mutations.
|
25712764 |
2015 |
Squamous cell carcinoma of the head and neck
|
0.060 |
Biomarker
|
disease |
BEFREE |
We previously demonstrated that overexpression of the DNA double-strand break repair protein NBS1 is a prognostic marker of advanced head and neck squamous cell carcinoma (HNSCC).
|
20175780 |
2010 |
Advanced Head and Neck Squamous Cell Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
We previously demonstrated that overexpression of the DNA double-strand break repair protein NBS1 is a prognostic marker of advanced head and neck squamous cell carcinoma (HNSCC).
|
20175780 |
2010 |
Malignant neoplasm of breast
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
We performed genetic association studies in a population-based breast cancer case-control study analysing polymorphisms in genes involved in homologous recombination (NBS1, RAD52, RAD51, XRCC2 and XRCC3) and non-homologous end-joining (KU70/80 and LIG4).
|
12023982 |
2002 |
Breast Carcinoma
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
We performed genetic association studies in a population-based breast cancer case-control study analysing polymorphisms in genes involved in homologous recombination (NBS1, RAD52, RAD51, XRCC2 and XRCC3) and non-homologous end-joining (KU70/80 and LIG4).
|
12023982 |
2002 |
Nijmegen Breakage Syndrome
|
1.000 |
AlteredExpression
|
disease |
BEFREE |
We observed that the HCAR1 agonist dihydroxybenzoic acid (DHBA) up-regulated BRCA1 (breast cancer type 1 susceptibility protein) and NBS1 (Nijmegen breakage syndrome 1) expression in HeLa cells.
|
28258841 |
2017 |
Malignant Head and Neck Neoplasm
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
We investigated whether genetic polymorphisms of the DNA repair gene NBN are associated with head and neck cancer risk.
|
21472885 |
2012 |
Head and Neck Carcinoma
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
We investigated whether genetic polymorphisms of the DNA repair gene NBN are associated with head and neck cancer risk.
|
21472885 |
2012 |
Nijmegen Breakage Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
We investigated the association of urinary bladder cancer with genetic polymorphisms in the xeroderma pigmentosum complementation group C (XPC), group D (XPD) and group G (XPG), X-ray repair cross-complementing group 1 (XRCC1) and group 3 (XRCC3), Nijmegen breakage syndrome 1 (NBS1), cyclin D1, methylene-tetrahydrofolate reductase (MTHFR), NAD(P)H dehydrogenase quinone 1 (NQO1), H-ras and glutathione S-transferase theta 1 (GSTT1) genes.
|
14688016 |
2004 |
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We investigated the association of urinary bladder cancer with genetic polymorphisms in the xeroderma pigmentosum complementation group C (XPC), group D (XPD) and group G (XPG), X-ray repair cross-complementing group 1 (XRCC1) and group 3 (XRCC3), Nijmegen breakage syndrome 1 (NBS1), cyclin D1, methylene-tetrahydrofolate reductase (MTHFR), NAD(P)H dehydrogenase quinone 1 (NQO1), H-ras and glutathione S-transferase theta 1 (GSTT1) genes.
|
14688016 |
2004 |
Nijmegen Breakage Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
We investigated the 657del5 carrier status of cancer patients among blood relatives (i.e., first-, through fourth-degree relatives) of NBS patients in the Czech Republic and Slovakia to test the hypothesis that NBN heterozygotes have an increased cancer risk.
|
18073374 |
2007 |
Liver and Intrahepatic Biliary Tract Carcinoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We hypothesized that polymorphisms of NBS1 are associated with hepatic cancer (HCC) risk.
|
22070649 |
2012 |